Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world enalaprilat use in hypertensive emergencies
ChiCTR2400092571Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of enalaprilat in hypertensive emergency, sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: Post-medication blood pressure change curve and Blood pressure reduction magnitude and target attainment at 6 hours. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
enalaprilat
03
Conditions
hypertensive emergency
Beyond the preview
Go deeper on ChiCTR2400092571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092571.